Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer-Reference-Cited by-同舟云学术

Systematic review and meta-analysis of C-reactive protein as a biomarker in breast cancer

Published:2022-04-09 Issue:7 Volume:59 Page:480-500
ISSN:1040-8363
Container-title:Critical Reviews in Clinical Laboratory Sciences
language:en
Short-container-title:Critical Reviews in Clinical Laboratory Sciences

Author:

Mikkelsen Marta Kramer¹,Lindblom Nana Aviaja Frederikke¹,Dyhl-Polk Anne¹,Juhl Carsten Bogh²³,Johansen Julia Sidenius¹⁴⁵,Nielsen Dorte¹⁵

Affiliation:

1. Department of Oncology, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

2. Department of Physiotherapy and Occupational Therapy, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

3. Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense M, Denmark

4. Department of Medicine, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark

5. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Publisher

Informa UK Limited

Subject

Biochemistry (medical),Clinical Biochemistry,General Biochemistry, Genetics and Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10408363.2022.2050886

Reference76 articles.

1. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods

2. Cancer Statistics, 2021

3. 4th ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)

4. National Cancer Institute. NCI dictionary of cancer terms. n.d. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/biomarker

5. Cancer biomarkers

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic and clinicopathological significance of C-reactive protein in patients with ovarian cancer: a meta-analysis;World Journal of Surgical Oncology;2024-01-03

2. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients;BMC Cancer;2023-12-05

3. PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification;Cellular Signalling;2023-12

4. Potential diagnostic and prognostic biomarkers for breast cancer: A compiled review;Pathology - Research and Practice;2023-11

5. Inflammation, Nutrition, and Clinical Outcomes in Breast Cancer Survivors: A Narrative Review;Current Nutrition Reports;2023-09-26